Kai Lü
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral Infections and Vectors
- Viral Infections and Outbreaks Research
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- Viral Infections and Outbreaks Research 7
- Viral Infections and Vectors 6
- SARS-CoV-2 and COVID-19 Research 4
- Viral gastroenteritis research and epidemiology 3
- Co-authors
- Graham Simmons (18 shared papers)Stefan Pöhlmann (4 shared papers)Yanchen Zhou (4 shared papers)Juliet Agudelo (3 shared papers)Jianan Wang (3 shared papers)Hong Yu (3 shared papers)Jerritt Nunneley (2 shared papers)Jinyun Zhu (2 shared papers)
- Journals
- Value in Health (4 papers)Journal of Virology (3 papers)Transfusion (3 papers)PLoS ONE (3 papers)International Journal of Environmental Research and Public Health (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Kai Lü
84 papers receiving 2.6k citations
Kai Lü's Hit Papers
Peers
Comparison fields: 5 of 131
- Infectious Diseases 754
- Cancer Research 245
- Immunology 254
- Public Health, Environmental and Occupational Health 330
- Endocrinology, Diabetes and Metabolism 161
Countries citing papers authored by Kai Lü
This map shows the geographic impact of Kai Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Lü more than expected).
Fields of papers citing papers by Kai Lü
This network shows the impact of papers produced by Kai Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Lü. The network helps show where Kai Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Protease inhibitors targeting coronavirus and filovirus entry Hit paper breakdown → | 2015 | 451 |
| 2 | 2017 | 235 | |
| 3 | 2017 | 129 | |
| 4 | 2010 | 119 | |
| 5 | 2017 | 117 | |
| 6 | 2011 | 93 | |
| 7 | 2016 | 84 | |
| 8 | 2014 | 77 | |
| 9 | 2020 | 67 | |
| 10 | 2011 | 60 | |
| 11 | 2014 | 58 | |
| 12 | 2017 | 57 | |
| 13 | 2015 | 56 | |
| 14 | 2015 | 55 | |
| 15 | 2013 | 54 | |
| 16 | 2013 | 53 | |
| 17 | 2015 | 50 | |
| 18 | 2014 | 49 | |
| 19 | 2017 | 46 | |
| 20 | 2017 | 43 |
About Kai Lü
Kai Lü is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases, Molecular Biology, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism, having authored 86 papers that have together received 2.6k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (9 papers), Viral Infections and Outbreaks Research (7 papers), Viral Infections and Vectors (6 papers), Diabetes Treatment and Management (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Sleep and related disorders (4 papers), Viral gastroenteritis research and epidemiology (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). The work is most often cited by research in Infectious Diseases (754 citations), Cancer Research (245 citations), Immunology (254 citations), Public Health, Environmental and Occupational Health (330 citations) and Endocrinology, Diabetes and Metabolism (161 citations). Kai Lü has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Graham Simmons, Stefan Pöhlmann, Yanchen Zhou, Juliet Agudelo, Jianan Wang, Hong Yu, Jerritt Nunneley, Jinyun Zhu, Jun Shen and Hu Liu. Their work appears in journals such as Value in Health, Journal of Virology, Transfusion, PLoS ONE and International Journal of Environmental Research and Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.